The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Alternative routes of insulin delivery
Abstract
Attempts at replicating physiological insulin secretion, as a means of restoring the normal metabolic milieu and thereby minimizing the risk of diabetic complications, has become an essential feature of insulin treatment. However, despite advances in the production, purification, formulation and methods of delivery of insulin which have occurred in recent years, this has met with limited success. The current advocacy of intensive insulin therapy regimens involving multiple daily subcutaneous injection places a heavy burden of compliance on patients and has prompted interest in developing alternative, less invasive routes of delivery. To date, attempts to exploit the nasal, oral, gastrointestinal and transdermal routes have been mainly unsuccessful. The respiratory tree, with a large surface area, offers the greatest potential for the delivery of polypeptide drugs and there is renewed interest in administrating insulin by the intrapulmonary route. Current pulmonary drug delivery systems include a variety of pressurized metered dose inhalers, dry powder inhalers, nebulizers and aqueous mist inhalers. Recent clinical studies suggest a possible role for inhaled insulin in fulfilling meal‐related insulin requirements in persons with Type 1 and Type 2 diabetes. Most experience with inhaled insulin has been obtained using either dry powder formulation in the Nektar Pulmonary Inhaler/Exubera device (Nektar Therapeutics Inc., San Carlos, CA, Aventis, Bridgewater, NJ, Pfizer, NY) or a liquid aerosol formulation in the AERx® Insulin Diabetes Management System (Aradigm Corp., Hayward, CA, NovoNordisk A/S, Copenhagen, Denmark). If long‐term safety and efficacy is confirmed, inhalation may become the first non‐subcutaneous route of insulin administration for widespread clinical use. Despite overwhelming interest and investment in administering insulin via the oral route, success is not expected in the short term. Attempts at utilizing the buccal mucosa and skin are also continuing. Pancreatic transplantation will remain limited to those patients receiving a kidney transplant and immunotherapy. Islet cell transplantation is at an early though encouraging stage following the availability of new less toxic immunosuppressive agents. True insulin independence will require further advances in the combined fields of cell biology and genetics to ensure freedom from both the need for lifelong administration of insulin and the complications of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Effects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Biologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823
Ultrasound-Mediated Transdermal Protein Delivery
Mitragotri, S., Blankschtein, D., & Langer, R. (1995) · Science · doi:10.1126/science.7638603 · Cited by 791
Mechanisms of macromolecule absorption by the lungs
Patton, J. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00113-l · Cited by 641
Cevc, G. (1996) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v13.i3-4.30 · Cited by 506
Owens, D. R., Zinman, B., & Bolli, G. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05842-1 · Cited by 373
Self-citationCarino, G. P., & Mathiowitz, E. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00075-1 · Cited by 347
Binder, C., Lauritzen, T., Faber, O., & Pramming, S. (1984) · Diabetes Care · doi:10.2337/diacare.7.2.188 · Cited by 341
Recent advances in pulmonary drug delivery using large, porous inhaled particles
Edwards, D. A., Ben-Jebria, A., & Langer, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.2.379 · Cited by 341
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
Skyler, J. S., Cefalu, W. T., Kourides, I. A., Landschulz, W. H., Balagtas, C. C., Cheng, S.-L., & Gelfand, R. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03638-2 · Cited by 301
Byron, P. R. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750502 · Cited by 253
(D) Routes of delivery: Case studies
Patton, J. S., & Platz, R. M. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90002-8 · Cited by 249
Chaillous, L., Lefèvre, H., Thivolet, C., Boitard, C., Lahlou, N., Atlan-Gepner, C., Bouhanick, B., Mogenet, A., Nicolino, M., Carel, J.-C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02579-4 · Cited by 248
Galloway, J. A., Spradlin, C. T., Nelson, R. L., Wentworth, S. M., Davidson, J. A., & Swarner, J. L. (1981) · Diabetes Care · doi:10.2337/diacare.4.3.366 · Cited by 226
Pozzilli, P., Pitocco, D., Visalli, N., Cavallo, M. G., Buzzetti, R., Crinò, A., Spera, S., Suraci, C., Multari, G., Cervoni, M., et al. (2000) · Diabetologia · doi:10.1007/s001250051482 · Cited by 217
New horizons — alternative routes for insulin therapy
Owens, D. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd836 · Cited by 209
Self-citationInhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus
Cefalu, W. T., Skyler, J. S., Kourides, I. A., Landschulz, W. H., Balagtas, C. C., Cheng, S.-L., Gelfand, R. A., & for the Inhaled Insulin Study Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-3-200102060-00011 · Cited by 199
Patton, J. S., Bukar, J., & Nagarajan, S. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00074-x · Cited by 193
ORAL TOLERANCE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
Weiner, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.341 · Cited by 191
Intranasal Aerosolized Insulin: Mixed-Meal Studies and Long-Term Use in Type I Diabetes
Salzman, R., Manson, J. E., Griffing, G. T., Kimmerle, R., Ruderman, N., McCall, A., Stoltz, E. I., Mullin, C., Small, D., Armstrong, J., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504253121702 · Cited by 187
Lipotoxicity in Human Pancreatic Islets and the Protective Effect of Metformin
Lupi, R., Del Guerra, S., Fierabracci, V., Marselli, L., Novelli, M., Patanè, G., Boggi, U., Mosca, F., Piro, S., Del Prato, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s134 · Cited by 186
Hinchcliffe, M., & Illum, L. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00073-8 · Cited by 180
Self-assembled “nanocubicle” as a carrier for peroral insulin delivery
Chung, H., Kim, J., Um, J. Y., Kwon, I. C., & Jeong, S. Y. (2002) · Diabetologia · doi:10.1007/s00125-001-0751-z · Cited by 166
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat
Kisel, M. A., Kulik, L. N., Tsybovsky, I. S., Vlasov, A. P., Vorob'yov, M. S., Kholodova, E. A., & Zabarovskaya, Z. V. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00579-8 · Cited by 161
HYPOGLYCqMIC EFFECT OF LIPOSOME-ENTRAPPED INSULIN ADMINISTERED INTRAGASTRICALLY INTO RATS
DAPERGOLAS, G., & Gregoriadis, G. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91209-5 · Cited by 154
Nasal Absorption of Insulin in Dogs
Hirai, S., Ikenaga, T., & Matsuzawa, T. (1978) · Diabetes · doi:10.2337/diab.27.3.296 · Cited by 147
Glycemic Control and Cardiopulmonary Function in Patients With Insulin-Dependent Diabetes Mellitus
Niranjan, V., McBrayer, D. G., Ramirez, L. C., Raskin, P., & Hsia, C. C. W. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00251-9 · Cited by 131
2, T. E. S. (2000) · Diabetologia · doi:10.1007/s001250050006 · Cited by 129
Delivery of Bioactive Peptides and Proteins Across Oral (Buccal) Mucosa
Senel, S., Kremer, M. J., Katalin, N., & Squier, C. A. (2001) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201013378734 · Cited by 119
Treatment Satisfaction With Inhaled Insulin in Patients With Type 1 Diabetes
Gerber, R. A., Cappelleri, J. C., KOURIDES, I. A., & Gelfand, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1556 · Cited by 114
Development of oral insulin: progress and current status
Still, J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.207 · Cited by 110
Variation in125i-insulin absorption and blood glucose concentration
Lauritzen, T., FABER, O. K., & Binder, C. (1979) · Diabetologia · doi:10.1007/bf01235885 · Cited by 110
The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist? System
Modi, P. J., Mihic, M., & Lewin, A. J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.208 · Cited by 106
Metered-Dose Inhalers, Dry Powder Inhalers, and Transitions
Fink, J. B. (2000) · Respiratory Care · doi:10.1177/002013240004500606 · Cited by 105
Direct Current Iontophoretic Transdermal Delivery of Peptide and Protein Drugs
Chien, Y. W., Siddiqui, O., Shi, W., Lelawongs, P., & Liu, J.-C. (1989) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600780507 · Cited by 105
Barnett, A. H., & Owens, D. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)06032-1 · Cited by 104
Self-citationProtein Delivery: Physical Systems
(2002) · Pharmaceutical Biotechnology · doi:10.1007/b112382 · Cited by 103
Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.
Pontiroli, A. E., Alberetto, M., Secchi, A., Dossi, G., Bosi, I., & Pozza, G. (1982) · BMJ · doi:10.1136/bmj.284.6312.303 · Cited by 103
Dose-response relation of liquid aerosol inhaled insulin in Type I diabetic patients
Brunner, G. A., Balent, B., Ellmerer, M., et al. (2001) · Diabetologia · doi:10.1007/s001250051618 · Cited by 103
Bile salts and intranasal drug absorption
Duchateau, G. S. M. J. E., Zuidema, J., & Merkus, F. W. H. M. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90153-5 · Cited by 98
Kipnes, M. S., Dandona, P., Tripathy, D., Still, J., & Kosutic, G. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.421 · Cited by 96
Pfützner, A., Mann, A. E., & Steiner, S. S. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/152091502320798204 · Cited by 91
(D) Routes of delivery: Case studies
Cullander, C., & Guy, R. H. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90006-c · Cited by 87
Langkjær, L., Brange, J., Grodsky, G. M., & Guy, R. H. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00155-7 · Cited by 86
Lipid-dependent control of hepatic glycogen stores in healthy humans
Stingl, H., Krššák, M., Krebs, M., Bischof, M. G., Nowotny, P., Fürnsinn, C., Shulman, G. I., Waldhäusl, W., & Roden, M. (2001) · Diabetologia · doi:10.1007/s001250051579 · Cited by 85
Clement, S., Still, J. G., Kosutic, G., & McAllister, R. G. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/152091502760306544 · Cited by 84
Intranasal insulin therapy: the clinical realities
Hilsted, J., Madsbad, S., HVIDBERG, A. D., Rasmussen, M. H., Krarup, T., Ipsen, H.-H., Hansen, B., Pedersen, M., Djurup, R., & Oxenb�ll, B. (1995) · Diabetologia · doi:10.1007/bf00401839 · Cited by 78
Polymerized liposomes as potential oral vaccine carriers: Stability and bioavailability
Chen, H., Torchilin, V. P., & Langer, R. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01459-9 · Cited by 76
Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus
Ramirez, L. C., Nogare, A. R. D., Hsia, C. C. W., Arauz, C., Butt, I., Strowig, S. M., Schnurr-Breen, L., & Raskin, P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90154-p · Cited by 76
Phospholipid Deformable Vesicles for Buccal Delivery of Insulin.
Yang, T.-Z., Wang, X., Yan, X., & Zhang, Q. (2002) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.50.749 · Cited by 75
Parenteral absorption of insulin from the lung in diabetic children
Elliott, R. B., EDGAR, B. W., Pilcher, C. C., et al. (1987) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1987.tb00275.x · Cited by 73
Farr, S. J., McElduff, A., Mather, L. E., Okikawa, J. K., Ward, M., Gonda, I., Ličko, V., & Rubsamen, R. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050025131 · Cited by 72
Effect of Inspiratory Flow Rate on Respiratory Rate in Intubated Ventilated Patients
CORNE, S., Gillespie, D., ROBERTS, D. E., & Younes, M. K. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9607031 · Cited by 70
Liposomes as a carrier for oral administration of insulin: Effect of formulation factors
Choudhari, K. B., Labhasetwar, V. D., & Dorle, A. K. (1994) · Journal of Microencapsulation · doi:10.3109/02652049409040461 · Cited by 67
Non-invasive assessment of the effects of iontophoresis on human skin in-vivo
Curdy, C., Kalia, Y. N., & Guy, R. H. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776117 · Cited by 66
Sustained release of insulin from insoluble inhaled particles
Rita Vanbever, A., Jebria, A. B., Mintzes, J. D., Langer, R., & Edwards, D. A. (1999) · Drug Development Research · doi:10.1002/(sici)1098-2299(199912)48:4<178::aid-ddr5>3.0.co;2-i · Cited by 56
Intranasal administration of insulin to humans
Gizurarson, S. S., & Bechgaard, E. (1991) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(91)90083-p · Cited by 56
Long-Term Use of Intranasal Insulin in Insulin-Dependent Diabetic Patients
Frauman, A. G., Cooper, M. E., Parsons, B. J., Jerums, G., & Louis, W. J. (1987) · Diabetes Care · doi:10.2337/diacare.10.5.573 · Cited by 55
Merkus, F. W. H. M., Schipper, N. G. M., & Verhoef, J. C. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01357-0 · Cited by 55
Exercise increases the lung clearance of inhaled technetium-99m DTPA.
Meignan, M. A., Rosso, J., Leveau, J., Katz, A., Cinotti, L., Madelaine, G., & Galle, P. R. (1986) · PubMed · Cited by 46
Gwinup, G., Elias, A. N., & Domurat, E. S. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90440-h · Cited by 40
Chavakis, E., Riecke, B., Lin, J., Linn, T., Bretzel, R. G., Preissner, K. T., Brownlee, M., & Hammes, H. (2002) · Diabetologia · doi:10.1007/s00125-001-0727-z · Cited by 37
The Effect of Nicotine on Pulmonary Epithelial Permeability in Man
Minty, B. D., Royston, D., Jones, J. G., & HULANDS, G. H. (1984) · CHEST Journal · doi:10.1378/chest.86.1.72 · Cited by 37
Lalej-Bennis, D., Boillot, J., Bardin, C., Zirinis, P., Coste, A., Escudier, E., Chast, F., Peynegre, R., Sélam, J. L., & Slama, G. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00528.x · Cited by 35
Chan, H., Daviskas, E., Eberl, S., Robinson, M., Bautovich, G. J., & Young, I. H. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050393 · Cited by 35
Lalej-Bennis, D., Boillot, J., Bardin, C., Zirinis, P., Coste, A., Escudier, E. F., Chast, F., Peynegre, R., Slama, G., & Sélam, J. L. (2001) · PubMed · Cited by 31
Meal‐time Intranasal Insulin Delivery in Type 2 Diabetes
Bruce, D. G., Chisholm, D. J., Storlien, L. H., Borkman, M., & Kraegen, E. W. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01611.x · Cited by 24
Sustained efficacy and pulmonary safety of inhaled insulin during 2 years of outpatient therapy
Cefalu, W., Balagtas, C. C., Landschulz, W. H., et al. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)81705-2 · Cited by 19
Cited by
Pharmaceutical Particle Engineering via Spray Drying
Vehring, R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9475-1 · Cited by 1,691
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Oral Delivery of Peptide Drugs: Barriers and Developments
Hamman, J. H., Enslin, G. M., & Kotz??, A. F. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00003 · Cited by 499
Dry Powder Inhaler Formulation
Telko, M. J., & Hickey, A. J. (2005) · Respiratory Care · doi:10.4187/respcare.05501209 · Cited by 498
Avadi, M. R., Sadeghi, A. M. M., Mohammadpour, N., Abedin, S., Atyabi, F., Dinarvand, R., & Rafiee-Tehrani, M. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.007 · Cited by 400
Metadata
- Authors
- Owens, D. R., Zinman, B., & Bolli, G.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2003-10-22
- Volume
- 20
- Issue
- 11
- Pages
- 886-898
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2091918414
- Cited by
- 332
- References
- 71
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.